UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reaffirmed by stock analysts at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday, October 17th. They currently have a $208.00 target price on the healthcare conglomerate’s stock. Cantor Fitzgerald’s price target indicates a potential downside of 1.96% from the stock’s previous close. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2017 earnings at $10.00 EPS and FY2018 earnings at $10.85 EPS.
Several other equities analysts have also weighed in on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Morgan Stanley increased their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, June 28th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Deutsche Bank AG raised their price target on UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, July 13th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $216.65.
Shares of UnitedHealth Group (NYSE:UNH) traded down $0.71 during trading hours on Tuesday, reaching $212.16. The company’s stock had a trading volume of 1,527,115 shares, compared to its average volume of 3,400,000. UnitedHealth Group has a 52-week low of $136.22 and a 52-week high of $213.93. The company has a market capitalization of $205,090.00, a PE ratio of 22.17, a price-to-earnings-growth ratio of 1.58 and a beta of 0.64. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.17 earnings per share. equities research analysts forecast that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 72,149 shares of company stock valued at $14,212,342. Company insiders own 0.89% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC raised its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter worth $110,000. Kings Point Capital Management raised its position in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares in the last quarter. Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares in the last quarter. 86.17% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.